marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2023-Q1
added 06-29-2023
Idera Pharmaceuticals Financial Statements 2011-2024 | IDRA
Annual Financial Statements Idera Pharmaceuticals
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
1.4 M | 1.65 M | 189 M | 49.1 M | 70.5 M | 291 M | 172 M | 223 M | 374 M | 181 M | 19.9 M | 29.8 M |
Shares |
3.26 M | 2.89 M | 33.8 M | 28.5 M | 26.6 M | 19.7 M | 15.9 M | 14.4 M | 10.4 M | 5.49 M | 3.45 M | 3.45 M |
Historical Prices |
0.43 | 0.57 | 3.67 | 1.82 | 2.77 | 16.9 | 12 | 24.7 | 35.3 | 37 | 7.12 | 8.4 |
Net Income |
-23.4 M | 98.1 M | -113 M | -56.5 M | -59.9 M | -66 M | -38.4 M | -48.6 M | -38.6 M | -18.2 M | -19.2 M | -23.8 M |
Revenue |
4.86 M | - | - | 1.45 M | 662 K | 902 K | 16.2 M | 249 K | 73 K | 47 K | 51 K | 53 K |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | 53 K |
Operating Income |
-27.8 M | -27.7 M | -36.7 M | -46.1 M | -61 M | -66.5 M | -38.8 M | -48.8 M | -38.8 M | -18.2 M | -19.9 M | -25.9 M |
Interest Expense |
- | - | 3 K | - | 11 K | 50 K | 80 K | 105 K | 27 K | - | - | - |
EBITDA |
-27.7 M | -27.6 M | -36.6 M | -45.8 M | -56.2 M | -65.7 M | -38.1 M | -48.4 M | -38.5 M | -18 M | -19.6 M | -25.4 M |
Operating Expenses |
32.7 M | 27.7 M | 36.7 M | 47.3 M | 57.3 M | 67.4 M | 55 M | 49.1 M | 38.8 M | 18.2 M | 20 M | 25.9 M |
General and Administrative Expenses |
12.2 M | 9.98 M | 11.9 M | 12.5 M | 15.4 M | 16.7 M | 15.1 M | 15.4 M | 11.3 M | 7.74 M | 6.28 M | 7.94 M |
All numbers in USD currency
Quarterly Income Statement Idera Pharmaceuticals
| 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
7.45 M | 3.65 M | 53.3 M | 53 M | 3.11 M | 52.8 M | 52.7 M | 49.9 M | 41.2 M | 38.3 M | 35.1 M | 33.6 M | 30.3 M | 29.7 M | 28.8 M | 28.5 M | 27.7 M | 27.2 M | 27.2 M | 27.1 M | 24.9 M | 24.5 M | 18.7 M | 18.7 M | 149 M | 149 M | 121 M | 121 M | 121 M | 121 M | 118 M | 118 M | 105 M | 94.8 M | 84.5 M | 83 M | 76 M | 66.3 M | 45.7 M | 38 M | 27.6 M | 27.6 M | 27.6 M | 27.6 M | 27.6 M | 27.6 M | 27.6 M | 27.6 M | 27.6 M |
Net Income |
-21.9 M | - | -3.1 M | -5.31 M | -4.18 M | - | -5.96 M | -7.56 M | 116 M | - | -20.6 M | -24.2 M | 8.82 M | - | -11.1 M | -11.2 M | -11 M | - | -11.6 M | -16 M | -20.1 M | - | -14.5 M | -21.5 M | -15.1 M | - | -12.9 M | -13.5 M | -12.8 M | - | -11.4 M | -12.7 M | -12.5 M | - | -9.46 M | -8.31 M | -8.96 M | - | -4.74 M | -3.59 M | -3.81 M | - | -4.67 M | -3.89 M | -6.89 M | - | -5.49 M | -6.28 M | -6.84 M |
Revenue |
2.47 M | - | 49 K | - | - | - | - | - | - | - | - | - | - | - | 1.45 M | 1.45 M | - | - | 145 K | 163 K | 255 K | - | 164 K | 187 K | 378 K | - | 323 K | 301 K | 294 K | - | 20 K | 5 K | 34 K | - | 30 K | 38 K | 3 K | - | 7 K | 29 K | 7 K | - | 3 K | 28 K | 9 K | - | 4 K | 33 K | 8 K |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-20.6 M | - | -9.33 M | -5.36 M | -4.18 M | - | -5.97 M | -7.56 M | -10 M | - | -7.48 M | -8.01 M | -13.2 M | - | -11.4 M | -11.5 M | -11.4 M | - | -11.9 M | -16.3 M | -20.3 M | - | -14.7 M | -21.6 M | -15.2 M | - | -13 M | -13.6 M | -12.9 M | - | -11.5 M | -12.8 M | -12.5 M | - | -9.52 M | -8.33 M | -8.97 M | - | -4.68 M | -3.57 M | -3.85 M | - | -4.75 M | -5.32 M | -5.49 M | - | -5.52 M | -6.28 M | -6.83 M |
Interest Expense |
-185 K | - | - | - | 3 K | - | 7 K | 4 K | 3 K | - | - | - | - | - | - | - | - | - | 11 K | 4 K | 7 K | - | 11 K | 13 K | 16 K | - | 19 K | 21 K | 23 K | - | 27 K | -27 K | -27 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
-20.6 M | - | -9.32 M | -5.36 M | -4.18 M | - | -5.95 M | -7.55 M | -9.93 M | - | -7.43 M | -7.97 M | -13.1 M | - | -11.3 M | -11.4 M | -11.3 M | - | -11.8 M | -16.2 M | -20.1 M | - | -14.5 M | -21.4 M | -15 M | - | -12.8 M | -13.4 M | -12.7 M | - | -11.3 M | -12.7 M | -12.4 M | - | -9.46 M | -8.28 M | -8.94 M | - | -4.65 M | -3.53 M | -3.81 M | - | -4.7 M | -5.26 M | -5.41 M | - | -5.4 M | -6.15 M | -6.7 M |
Operating Expenses |
23.1 M | - | 9.38 M | 5.36 M | 4.18 M | - | 5.97 M | 7.56 M | 10 M | - | 7.48 M | 8.01 M | 13.2 M | - | 11.4 M | 13 M | 11.4 M | - | 12 M | 16.5 M | 20.5 M | - | 14.8 M | 21.8 M | 15.6 M | - | 13.3 M | 13.9 M | 13.2 M | - | 11.5 M | 12.8 M | 12.6 M | - | 9.55 M | 8.37 M | 8.98 M | - | 4.69 M | 3.6 M | 3.86 M | - | 4.76 M | 5.35 M | 5.5 M | - | 5.52 M | 6.31 M | 6.84 M |
General and Administrative Expenses |
4.92 M | - | 2.27 M | 2.66 M | 2.4 M | - | 2.33 M | 2.47 M | 3.16 M | - | 2.72 M | 2.63 M | 3.64 M | - | 3.02 M | 2.9 M | 3.14 M | - | 3.98 M | 4 M | 3.48 M | - | 3.92 M | 3.89 M | 4.08 M | - | 3.91 M | 3.78 M | 3.92 M | - | 4.03 M | 3.82 M | 3.84 M | - | 2.87 M | 2.73 M | 2.04 M | - | 2.18 M | 1.6 M | 1.53 M | - | 1.48 M | 1.85 M | 1.69 M | - | 1.95 M | 2.17 M | 2.29 M |
All numbers in USD currency